An interesting case report on 59-year-old woman. Patient get a malignant melanoma and receiving checkpoint inhibition therapy with pembrolizumab. The patient developed arthritis of the right knee at week 30.
doi: 10.1097/MD.0000000000019439
First released 25 jan 2020